ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

AHG vs V // EV/EBITDA & P/E VALUATION

Akso Health Group ADS (NASDAQ) VS. Visa Inc. (NYSE) • 15-METRIC TALLY: AHG 0 — V 8
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AHG VS. V) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC AHG V SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin -0.10% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) — 32.30% — TIE /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — 28.9x — TIE /valuation <GO>
Free Cash Flow Yield -1.12% 2.90% -4.02 V /fcf-yield <GO>
Operating Margin -60.00% 60.00% -120.00 V /operating-margins <GO>
Net Profit Margin -60.00% 50.10% -110.10 V /net-margins <GO>
Revenue Growth (YoY) -6.40% 11.30% -17.70 V /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.63% -0.63 V /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 9.09 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 9/9 -7.00 V /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 53.8 65.6 -11.84 V /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 1.06 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 34.0x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $1.14B $733.53B -$732.40B V /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR AHG REV V REV AHG GROSS % V GROSS % AHG FCF V FCF
FY 2025 $13.8M $40.00B -0.1% — -$12.8M $21.26B
FY 2024 $14.8M $35.93B -1.9% — $1.0M $18.33B
FY 2023 $2.4M $32.65B — — $1.4M $19.29B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AHG // BETA —
V // BETA 1.06